Last reviewed · How we verify
NCT06636409
Long-term Mortality Post Liver Transplantation in the Era of Modern Immunosuppression.
trial testing Collection of medical data in Liver Transplant in 1,343 participants. Participants enrolled and being followed up; not accepting new ones.
30 July 2028
Quick facts
| Lead sponsor | University Hospital, Montpellier |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 1,343 |
| Start date | 1 August 2023 |
| Primary completion | 30 July 2028 |
| Estimated completion | 1 August 2028 |
| Sites | 1 location across France |
Drugs / interventions tested
- Collection of medical data
Conditions studied
- Liver Transplant — all drugs for Liver Transplant →
Sponsor
University Hospital, Montpellier
Who can join
Eligibility, any sex, with Liver Transplant. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Liver transplantation is the primary intervention for decompensated chronic liver diseases and some cases of hepatocellular carcinoma. This study aims to examine long-term mortality after liver transplantation and identify related risk factors in the modern immunosuppression era, using a French multicenter cohort. This study does not interfere with patients' medical care. The study method involves collecting and analyzing only the essential data from patient records.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Long-term outcomes and temporal trends following liver transplantation for chronic liver disease in the intensive care unit.
Meszaros M, Ursic-Bedoya J, Coilly A, Francoz C, et al · · 2026 · PMID 41810429 · DOI 10.1016/j.jhepr.2025.101722
Verify or expand the search:
- PubMed search for NCT06636409
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Collection of medical data
Trials testing the same drug.
- NCT06618833 — Medical and Sociological Characterization of the Population of Patients Admitted for a First Ablation of Atrial Fibrilla · NA · recruiting
- NCT05154071 — Impact of the Implementation of a Referral Veno-venous Extracorporeal Membrane Oxygenation Centre on Mortality · completed
Other recruiting trials for Liver Transplant
Currently open trials in the same condition.
- NCT06254248 — Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma · Phase 2 · recruiting
- NCT06832189 — EVR and EPO for Liver Transplant Tolerance · Phase 1 · recruiting
- NCT07216508 — Liver Transplant CGM · recruiting
- NCT07086989 — Cardiovascular Risk in Children With Chronic Conditions Study · recruiting
- NCT06813508 — Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH · recruiting
Other University Hospital, Montpellier trials
Trials by the same sponsor.
- NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
- NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
- NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
- NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
- NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06636409 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
- Last refreshed: 10 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06636409.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing